NCT02062671Unknown不适用
Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- Pain
研究概览
简要总结
In patients with polycystic kidney disease, pain may be resistant to drug therapy and may reduce quality of life. This study investigate the effect of renal denervation on this pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pain limiting daily activities in spite of pain killers, ADPKD
排除标准
- •Pregnancy
结局指标
主要结局
Pain
时间窗: 6 months
Pain from VAS
次要结局
- Quality of Life (QoL)(6 months)
研究者
Hans Dieperink
Head of Department, MD
Odense University Hospital
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Renal Sympathetic Denervation in Mild Refractory HypertensionRefractory HypertensionNCT01656096University of Leipzig71
已完成
不适用
Renal Sympathectomy in dialysis-dependent patients to reduce cardiovascular risk. A pilot studyEnd Stage Kidney DiseaseRenal and Urogenital - Kidney diseaseCardiovascular - Other cardiovascular diseasesCardiovascular - HypertensionACTRN12613000562774niversity of Otago15
已完成
不适用
Renal Denervation to Improve Outcomes in Patients With End-stage Renal DiseaseEnd-stage Renal DiseaseHypertensionNCT02021019Baker Heart and Diabetes Institute3
Unknown
2 期
Effect of Renal Sympathetic Denervation on Resistant Hypertension and Cardiovascular Hemodynamic in Comparison to Intensive Medical Therapy Utilizing Impedance CardiographyHypertension, Resistant to Conventional TherapyNCT01673516Oslo University Hospital60
终止
不适用
Impact of Renal SympAthetic DenerVation on Chronic HypErtensionUncontrolled HypertensionNCT01628198Vivek Reddy38
